News for Organon & Co. (OGN-WI)

Organon (NYSE: OGN), a global healthcare company with a focus on women's health, today announced results from an analysis of the Phase 3 ADORING 3 open-label,

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Organon & Co.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Organon & Co. (NYSE:OGN) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - CEOJuan...

The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The following slide deck was published by Organon & Co.

Organon (OGN) delivered earnings and revenue surprises of 4.65% and 1.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. ”œIn 2024 we achieved our third year of consta

Organon (OGN) concluded the recent trading session at $14.62, signifying a -1.81% move from its prior day's close.

The latest trading day saw Organon (OGN) settling at $15.97, representing a +0.82% change from its previous close.

Organon (OGN) closed at $16.26 in the latest trading session, marking a +1.82% move from the prior day.

Organon (OGN) closed the most recent trading day at $15.88, moving +0.89% from the previous trading session.

Organon has faced significant price volatility and underperformance since its spin-off from Merck. Check out why I recommend a hold for OGN stock in 2025.

Organon & Co. (NYSE:OGN) JPMorgan Annual Healthcare Conference Call January 13, 2025 6:45 PM ETCompany ParticipantsKevin Ali - Chief Executive...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Organon & Co.

Organon (OGN) closed at $15.85 in the latest trading session, marking a -0.94% move from the prior day.

Organon (OGN) shares trade lower after recent gains.

Organon (OGN) closed at $16 in the latest trading session, marking a +1.78% move from the prior day.